Bristol Myers Squibb presents transformative research in the treatment of genitourinary cancers at ASCO GU 2024.The group presents the first presentation of results from the phase 3 CheckMate -67T.
Bristol Myers Squibb has announced it has acquired Karuna Therapeutics, Inc., for a total equity value of $14 billion or $12.7 billion net of estimated cash.
Bristol Myers Squibb Acquires RayzeBio - San Diego Business Journal sdbj.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from sdbj.com Daily Mail and Mail on Sunday newspapers.